OTUB1 also inhibits the polyubiquitination of TRAF6 and the subsequent activation of the ASK1 signaling pathway, playing a critical protective role in non-alcoholic fatty liver disease [22]. Here, MAP3K5 is linked to metabolic dysfunction-associated steatotic liver disease.